Moreover, the protein levels of P62 were remarkably reduced, while Atg5, Beclin 1, and the LC3B-II/LC3B-I ratio were noticeably elevated in PA-treated NSCLC cells. This evidence concerns the gene BECN1 and non-small cell lung carcinoma.